Beam Therapeutics Inc.BEAMNASDAQ

Revenue (LTM)

$140M

+120.0% YoY

Net Income (LTM)

$-80M

+78.8% YoY

Free Cash Flow

$-360M

Revenue CAGR (5Y)

+466.3%

Marginsimproving

FCF($0.4B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	52	61↑17.5%	378↑520.0%	64↓83.2%	140↑120.0%
Gross Profit	-180	-251↓39.0%	378↑250.7%	-304↓180.5%	117↑138.6%
Operating Income	-392	-338↑13.8%	-176↑47.9%	-416↓135.5%	-384↑7.7%
Net Income	-371	-289↑22.0%	-133↑54.2%	-377↓184.3%	-80↑78.8%
EBITDA	-230	-324↓41.0%	-147↑54.7%	-394↓167.9%	-30↑92.4%
EPS Diluted	-5.77	-4.13↑28.4%	-1.72↑58.4%	-4.58↓166.3%	-0.81↑82.3%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	560	233↓58.4%	436↑87.3%	282↓35.3%	295↑4.6%
Total Current Assets	1,273	1,093↓14.1%	1,211↑10.8%	878↓27.5%	1,269↑44.5%
Total Assets	1,474	1,342↓9.0%	1,460↑8.8%	1,104↓24.4%	1,481↑34.2%
Total Current Liabilities	213	224↑4.8%	206↓8.1%	182↓11.4%	97↓46.8%
Total Liabilities	648	608↓6.1%	478↓21.3%	370↓22.6%	243↓34.4%
Total Equity	827	733↓11.3%	981↑33.8%	734↓25.2%	1,238↑68.8%
Total Debt	148	179↑21.2%	173↓3.5%	161↓6.5%	294↑82.1%
Net Debt	-412	-54↑87.0%	-263↓389.6%	-121↑54.2%	-1↑99.1%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-66	23↑134.0%	-149↓762.3%	-347↓132.7%	-345↑0.6%
Capital Expenditure	-47	-49↓4.6%	-34↑31.1%	-9↑73.5%	-15↓67.1%
Free Cash Flow	-113	-26↑76.6%	-183↓592.3%	-356↓94.7%	-360↓1.1%
Stock-Based Comp	44	84↑93.5%	99↑17.0%	121↑22.3%	94↓21.9%
Net Change in Cash	396	-327↓182.7%	199↑160.8%	-155↓177.6%	12↑107.4%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance